关于陕西斯瑞新材料股份有限公司 向特定对象发行 A 股股票 之 发行保荐书 保荐机构（主承销商） （上海市广东路 689 号） 海通证券股份有限公司 声 明 本保荐机构及保荐代表人已根据《中华人民共和国公司法》（以下简称《公 司法》）、《中华人民共和国证券法》（以下简称《证券法》）、《上市公司证 券发行注册管理办法》（以下简称《注册管理办法》）、《上海证券交易所科创 板股票上市规则》（以下简称《上市规则》）等有关法律、法规，诚实守信，勤 勉尽责，严格按照依法制定的业务规则和行业自律规范出具证券发行保荐书，并 保证所出具文件真实、准确、完整。 如无特殊说明，本发行保荐书中的简称或名词释义与《陕西斯瑞新材料股份 有限公司 2024 年度向特定对象发行 A 股股票之募集说明书（申报稿）》一致。 3-1-1 | 声 | 明 1 | | --- | --- | | 目 | 录 2 | | 第一节 | 本次证券发行基本情况 3 | | | 一、本次证券发行保荐机构名称 3 | | | 二、保荐机构指定保荐代表人及保荐业务执业情况 3 | | | 三、保荐机构指定的项目协办人及其他项目人员 3 | | | 四、本次保荐的发 ...

海通证券股份有限公司 关于陕西斯瑞新材料股份有限公司 向特定对象发行 A 股股票 之 上市保荐书 保荐机构（主承销商） （上海市广东路 689 号） 二〇二五年三月 声 明 本保荐机构及其保荐代表人已根据《中华人民共和国公司法》（以下简称《公 司法》）、《中华人民共和国证券法》等法律法规和中国证券监督管理委员会（以 下简称"中国证监会"）及上海证券交易所的有关规定，诚实守信，勤勉尽责， 严格按照依法制定的业务规则和行业自律规范出具上市保荐书，并保证所出具文 件真实、准确、完整。 如无特殊说明，本上市保荐书中的简称或名词释义与《陕西斯瑞新材料股份 有限公司向特定对象发行 A 股股票之募集说明书（申报稿）》一致。 3-2-1 | 声 明 1 | | --- | | 目 录 2 | | 一、发行人基本情况 3 | | 二、发行人本次发行情况 15 | | 三、本次证券发行上市的项目保荐代表人、协办人及项目组其他成员保荐业 | | 务执业情况及承诺事项 18 | | 四、保荐机构是否存在可能影响公正履行保荐职责情形的说明 19 | | 五、保荐机构承诺事项 19 | | 六、本次证券发行上市履行的决策程序 20 | ...

证券代码：688102 证券简称：斯瑞新材 公告编号：2025-007 陕西斯瑞新材料股份有限公司 关于前期定期报告的更正公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 更正前： 公司主要销售客户情况 前五名客户销售额 42,142.91 万元，占年度销售总额 47.67%；其中前五名客 户销售额中关联方销售额 0 万元，占年度销售总额 0%。 重要内容提示： 本次更正仅影响公司 2021 年、2022 年及 2023 年年度报告中披露的"主 要销售客户及主要供应商情况"和"按欠款方归集的期末余额前五名的应收账款 情况"数据。 本次更正不涉及对财务报表的调整，对公司 2021 年、2022 年及 2023 年 度财务状况、经营成果和现金流信息没有影响。 陕西斯瑞新材料股份有限公司(以下简称"公司"）分别于 2022 年 4 月 25 日、 2023 年 4 月 26 日、2024 年 4 月 27 日在上海证券交易所网站（www.sse.com.cn） 披露了《2021 年年度报告》、《2022 年年度报告》和《20 ...

证券代码：688102 证券简称：斯瑞新材 公告编号：2025-008 陕西斯瑞新材料股份有限公司 1、2023 年 12 月 21 日，公司召开了第三届董事会独立董事专门会议第一 次会议、第三届董事会第十次会议，审议通过了《关于<公司 2023 年股票期权 激励计划(草案)>及其摘要的议案》《关于<公司 2023 年股票期权激励计划实施 考核管理办法>的议案》《关于提请股东大会授权董事会办理公司 2023 年股票 期权激励计划有关事项的议案》以及《关于提请召开公司 2024 年第一次临时股 东大会的议案》。同日，公司召开的第三届监事会第八次会议审议通过了《关 于<公司 2023 年股票期权激励计划(草案)>及其摘要的议案》《关于<公司 2023 年股票期权激励计划实施考核管理办法>的议案》《关于核实<公司 2023 年股票 期权激励计划首次授予激励对象名单>的议案》，公司监事会对本激励计划的相 关事项进行核实并出具相关核查意见。 2、2023 年 12 月 23 日，公司披露了《陕西斯瑞新材料股份有限公司 2023 年股票期权激励计划（草案）》《陕西斯瑞新材料股份有限公司 2023 年股票期 权激励计划（草 ...

国浩律师（西安）事务所 法 律 意 见 书 西安市雁塔区绿地中心 B 座 46 层 邮编：710065 The 46th Floor, Block B, Xi'an Greenland Center, Yanta District, Xi'an，710065,China 关 于 陕西斯瑞新材料股份有限公司 2023 年股票期权激励计划调整相关事项 之 电话/Tel: +86 29 8819 9711 网址/Website: http://www.grandall.com.cn 2025 年 4 月 | 第一节 | 引言 | 3 | | --- | --- | --- | | 一、释义 | | 3 | | 二、律师声明事项 | | 4 | | 第二节 | 正 文 6 | | | 一、本次调整所获得的批准和授权 | | 6 | | 二、本次调整的具体内容 | | 9 | | 10 | 三、结论意见 | | | 第三节 | 签署页 11 | | 国浩律师(西安)事务所 法律意见书 国浩律师（西安）事务所 关于陕西斯瑞新材料股份有限公司 2023 年股票期权激励计划调整相关事项之 法律意见书 本所律师根据《中华人民共 ...

证券代码：688102 证券简称：斯瑞新材 公告编号：2025-009 陕西斯瑞新材料股份有限公司 第三届监事会第十四次会议决议公告 一、监事会会议召开情况 本公司监事会及全体监事保证公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议的召开情况 陕西斯瑞新材料股份有限公司（以下简称"公司"）第三届监事会第十四次会议 于 2025 年 3 月 31 日（星期一）在公司 4 楼会议室以现场的方式召开。会议通知已于 2025 年 3 月 28 日送达各位监事，监事会会议通知中包括会议的相关材料，同时列明了 会议召开的时间、地点、内容及方式。本次会议应出席监事 3 人，实际出席监事 3 人， 均以现场方式参会。 会议由监事会主席王万刚主持。会议召开符合有关法律、法规、规章和《公司章 程》的规定。 经审议，监事会认为：公司对本次激励计划激励对象名单、授予数量及行权价格 的调整符合《上市公司股权激励管理办法》等相关法律、法规、规范性文件及公司 《2023 年股票期权激励计划（草案）》的相关规定。本次调整事项在公司 2024 年第一 次临时股东大会对董 ...

证券代码：688102 证券简称：斯瑞新材 公告编号：2025-010 陕西斯瑞新材料股份有限公司 本议案已经第三届薪酬与考核委员会第九次会议审议通过。 第三届董事会第十六次会议决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议的召开情况 陕西斯瑞新材料股份有限公司（以下简称"公司"）第三届董事会第十六次 会议（以下简称"本次会议"或"会议"）于 2025 年 3 月 31 日（星期一）在公 司 4 楼会议室以现场结合通讯的方式召开，会议通知已于 2025 年 3 月 28 日送 达各位董事。会议由董事长王文斌先生召集和主持，本次会议应出席董事 9 人， 实际出席董事 9 人（其中：通讯方式出席 6 人）。 本次会议的召集和召开程序符合《中华人民共和国公司法》《陕西斯瑞新材 料股份有限公司章程》等法律、法规和规范性文件的规定。 二、董事会会议审议情况 经与会董事审议，做出以下决议： 审议通过《关于调整公司 2023 年股票期权激励计划相关事项的议案》 经审议，董事会认为：鉴于公司 2023 年股票期权激 ...

Financial Performance - The company's operating revenue for 2022 was CNY 993,605,178, representing a year-over-year increase of 2.61% compared to CNY 968,292,220 in 2021[22]. - The net profit attributable to shareholders for 2022 was CNY 78,014,942.93, reflecting a growth of 23.13% from CNY 63,362,228.68 in 2021[23]. - The net cash flow from operating activities decreased by 29.54% to CNY 51,461,450.10 in 2022, down from CNY 73,036,334.56 in 2021[23]. - The total assets of the company as of the end of 2022 were CNY 1,497,113,659.06, an increase of 16.94% from CNY 1,280,194,077.20 at the end of 2021[22]. - The net assets attributable to shareholders increased by 69.35% to CNY 993,829,737.89 at the end of 2022, compared to CNY 586,850,590.01 at the end of 2021[23]. - The company's revenue for 2022 increased by 2.61% year-on-year, driven by significant growth in high-strength and high-conductivity copper alloy products and liquid rocket engine thrust chamber products[25]. - The overall revenue for the company reached approximately 926.85 million RMB, with a year-on-year growth of 4.86%[112]. - The gross profit margin for the non-ferrous metal segment was 19.60%, reflecting a decrease of 0.45 percentage points compared to the previous year[112]. Research and Development - The company is focused on developing new products and technologies, particularly in the fields of advanced materials and medical imaging equipment[16]. - The company maintains a strong commitment to research and development, investing in innovative solutions to meet market demands[16]. - Research and development expenses accounted for 5.19% of operating revenue, an increase of 0.99 percentage points from the previous year[24]. - The company invested 516.13 million RMB in R&D, marking a 27% increase compared to the previous period[39]. - The company has filed 71 new invention patents, bringing the total to 218 authorized invention patents by the end of the reporting period[39]. - The company has established a provincial-level advanced copper alloy innovation center to integrate social technology and talent resources[95]. - The R&D team consists of 79 members, with a significant portion holding advanced degrees, including 1 PhD and 16 master's degrees[92]. - The company achieved a total R&D investment of ¥51,612,919.99, representing a 26.77% increase compared to the previous year[81]. Market Expansion and Strategy - The company is exploring market expansion opportunities and potential mergers and acquisitions to enhance its competitive position[16]. - The company actively expanded into international markets, resulting in a significant increase in export revenue[25]. - The company is focusing on expanding its application areas for high-performance copper alloys to maintain its leading position in the industry[54]. - The company is actively pursuing mergers and acquisitions to enhance its competitive position in the industry[167]. - The company plans to enter two new international markets by Q3 2023, targeting a 30% increase in overseas sales[170]. - The company has successfully entered the U.S. market for CT and DR tube components, with a steady increase in domestic market share[37]. Corporate Governance - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[7]. - The company has not violated any decision-making procedures for providing guarantees[7]. - The company has not reported any instances where more than half of the board members could not guarantee the accuracy and completeness of the annual report[7]. - The board of directors held 8 meetings in 2022, approving 45 resolutions, in compliance with relevant regulations[156]. - The supervisory board convened 7 meetings in 2022, reviewing 18 resolutions, ensuring compliance with financial oversight responsibilities[157]. - The company has established a dedicated team for investor relations, actively engaging with shareholders to address inquiries and feedback[158]. - The company adheres to information disclosure regulations, ensuring transparency and equal access to information for all shareholders[158]. Investment and Capital Structure - The company plans to distribute a cash dividend of RMB 0.80 per 10 shares, totaling approximately RMB 32,000,800 (including tax) for the 2022 fiscal year[5]. - The company intends to increase its total share capital from 400,010,000 shares to 560,014,000 shares by issuing 4 new shares for every 10 shares held, resulting in a total of 160,004,000 new shares[5]. - The company completed a capital increase of RMB 356,910,828.82 to its wholly-owned subsidiary, Sui Rui Fu Feng, increasing its registered capital from RMB 60 million to RMB 400 million[138]. - The company has a total of RMB 32,661,905.20 in restricted assets, including cash and fixed assets, due to guarantees and collateral for loans[134]. Operational Efficiency - The company has implemented advanced manufacturing techniques such as 3D printing and vacuum induction melting to improve production efficiency[14]. - The company has optimized its vacuum casting technology, achieving a production capability of Cr content below 40%, which is currently a mainstream technology balancing quality and cost in the market[65]. - The company has achieved significant improvements in production efficiency and material utilization through the adoption of continuous extrusion processes for phosphorus-containing copper guide bars[62]. - The company is focusing on enhancing its operational efficiency through strategic investments in technology and process improvements[167]. Challenges and Risks - The company has identified potential risks in its business development, which are detailed in the management discussion and analysis section[3]. - The company faces risks related to technology upgrades and potential R&D failures, which could impact short-term performance and long-term sustainability[97]. - The company faces risks related to raw material price fluctuations, particularly copper prices, which could adversely affect financial performance[100]. - The company is monitoring international trade environment changes to mitigate potential impacts on its export business[106]. Future Outlook - The company aims to achieve carbon peak and carbon neutrality, aligning with the dual carbon goals[14]. - The company has set ambitious performance guidance for the next fiscal year, targeting a revenue increase of over 10%[166]. - The management team emphasized a commitment to sustainability, aiming for a 20% reduction in carbon emissions by 2025[170]. - The company is focused on technological innovation, aiming to hold over 50% of new patents globally in its niche materials sectors[147].

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the fiscal year 2021, representing a year-over-year growth of 15%[23]. - The company's operating revenue for 2021 reached ¥968,292,220.49, representing a 42.26% increase compared to ¥680,671,775.87 in 2020[25]. - Net profit attributable to shareholders increased by 21.60% to ¥63,362,228.68 in 2021, up from ¥52,105,260.30 in 2020[25]. - The basic earnings per share rose by 21.63% to ¥0.1760 in 2021, compared to ¥0.1447 in 2020[24]. - The company achieved a revenue of 968 million yuan in 2021, representing a year-on-year growth of 42.26%, and a net profit of 63.36 million yuan, up 21.60% year-on-year[35]. - The company reported a significant increase in revenue, achieving a total of $500 million, representing a 20% year-over-year growth[166]. - The company achieved a revenue of 1.5 billion, representing a year-over-year growth of 15%[165]. Research and Development - The company is investing RMB 100 million in R&D for new technologies, focusing on high-performance copper alloys and medical imaging equipment[23]. - R&D expenses increased to 40.71 million yuan, a year-on-year growth of 82.75%, resulting in 77 new invention patents, bringing the total to 149[36]. - The company has achieved a significant increase in R&D investment, totaling approximately ¥40.71 million, representing an 82.75% increase compared to the previous year[80]. - The company has filed 90 invention patents during the reporting period, with 77 granted, bringing the total granted patents to 149[77]. - The company is focusing on high-strength, high-conductivity copper alloy materials, which are essential for industries like new energy vehicles and 5G communications[148]. - The company is actively engaged in R&D projects, including national initiatives like the "Medical Device Material Production Application Demonstration Platform Project" and the "2020 Industrial Foundation Reconstruction and High-Quality Development Special Project"[42]. Market Expansion and Strategy - Future guidance estimates revenue growth of 10-15% for 2022, driven by market expansion and new product launches[23]. - Market expansion efforts include entering Southeast Asian markets, with a target of achieving 5% market share by the end of 2023[23]. - The company is considering strategic acquisitions to enhance its product portfolio and market presence, with potential targets identified in the medical device sector[23]. - The company is exploring strategic partnerships to leverage synergies and enhance operational efficiency[162]. - The company plans to add 40,000 tons of copper-iron and chromium-zirconium copper alloy production capacity over six years, with the first phase already under construction, emphasizing the need for effective market expansion strategies[103]. - The company is actively pursuing market expansion strategies, including potential mergers and acquisitions to enhance its competitive position[162]. Corporate Governance - The board of directors has confirmed the accuracy and completeness of the annual report, with no significant omissions or misleading statements[3]. - The board of directors was fully present at the meeting to approve the annual report[3]. - The company has established a governance structure that includes a board of directors, supervisory board, and specialized committees to enhance decision-making[155]. - The independent directors actively participated in meetings and provided objective judgments on proposals[154]. - The company maintained a transparent information disclosure policy, ensuring all shareholders had equal access to information[157]. - The company has established a modern corporate governance system to protect the rights of shareholders and creditors[188]. Risks and Challenges - The company has outlined potential risks in its business development in the report[5]. - The company is at risk of technological obsolescence if it fails to keep pace with industry advancements in new materials and manufacturing processes[101]. - The company faces risks related to the inability to commercialize new technologies or products, which could lead to unfulfilled R&D investments[102]. - The company is exposed to foreign exchange risks due to transactions with international clients, particularly in USD and EUR, which could impact revenue and profit margins[105]. - The company operates in stable growth industries, but faces risks from international political and economic changes that could impact its export-oriented products[109]. Sustainability and Social Responsibility - The company aims to achieve carbon neutrality by 2030, aligning with the national dual carbon goals[23]. - The company has been recognized as a green factory at both the provincial and national levels, emphasizing its commitment to environmental protection and sustainable development[193]. - The company actively engages in social responsibility initiatives, aiming to contribute to high-quality national development through its performance and services[192]. - The company has established a dedicated safety and environmental management department to oversee compliance with environmental regulations and standards[200]. Employee and Management - The total number of employees in the parent company and major subsidiaries is 1,114, with 762 in the parent company and 352 in subsidiaries[179]. - The company has increased its R&D personnel from 50 to 81, with R&D personnel now accounting for 7.27% of the total workforce[91]. - Employee welfare includes regular health check-ups, holiday benefits, and food subsidies, ensuring a safe working environment[189]. - The company has a performance evaluation system for different personnel, aimed at improving skills and productivity[180]. - The company has established a scientific and effective remuneration assessment mechanism for its board members and senior management[171]. Financial Management - The company has not yet achieved profitability since its listing[3]. - The company has not proposed any capital reserve transfer to increase share capital[4]. - The company has a centralized supply chain management model, ensuring stability and efficiency in procurement and logistics across its business units[43]. - The total cost of main business increased by 54.46% year-on-year, with direct materials accounting for 69.97% of total costs[123]. - The company’s financial expenses increased by 5.29% to ¥25,492,454.00 compared to the previous year[132].

Financial Performance - The company reported a revenue of RMB 1.2 billion for the fiscal year 2023, representing a year-over-year growth of 15%[16]. - The company's operating revenue for 2023 reached approximately ¥1.18 billion, representing an 18.71% increase compared to ¥993.61 million in 2022[25]. - Net profit attributable to shareholders for 2023 was approximately ¥98.34 million, a 26.04% increase from ¥78.03 million in 2022[25]. - Basic earnings per share (EPS) for 2023 was ¥0.1756, reflecting a 22.88% increase from ¥0.1429 in 2022[24]. - The net cash flow from operating activities surged by 227.56% to approximately ¥168.57 million in 2023, compared to ¥51.46 million in 2022[25]. - The gross margin for the year was reported at 35%, a slight increase from 32% in the previous year[16]. - The company achieved a significant increase in revenue, achieving a total of $500 million for the fiscal year, representing a 20% growth compared to the previous year[169]. - The company reported a year-on-year revenue growth of 15% in the latest fiscal year, reaching a total revenue of 1.2 billion RMB[171]. Dividend and Share Capital - The company plans to distribute a cash dividend of 0.80 CNY per 10 shares, totaling approximately 44.62 million CNY, which represents 48.31% of the net profit attributable to shareholders for 2023[4]. - The company intends to increase its share capital by 3 shares for every 10 shares held, resulting in an additional 167.32 million shares, raising the total share capital to approximately 727.34 million shares[5]. - The company has established a cash dividend policy that ensures a minimum of 30% of the average distributable profit over the last three years is distributed in cash[196]. - The company plans to increase its total share capital by 167,323,890 shares through a capital reserve transfer, raising the total share capital to 727,337,890 shares[198]. Research and Development - The company is investing RMB 100 million in R&D for new technologies in medical imaging equipment, aiming for a 15% improvement in imaging quality[16]. - R&D expenses for the period amounted to 59.45 million yuan, reflecting a year-on-year increase of 15.19%[42]. - The total R&D investment for the year reached ¥59,453,024.91, representing a 15.19% increase compared to the previous year[90]. - The company is focusing on personalized R&D services to meet the unique needs of its customers, driving innovation through collaboration with benchmark clients[53]. - The company has developed a series of advanced core technologies in high-strength, high-conductivity copper alloys, high-voltage contact materials, and other specialized fields, with multiple patents granted[70]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a 20% increase in sales from this region by 2025[16]. - The company is committed to expanding its international business, particularly in the medical imaging equipment sector, to enhance its market presence[37]. - The company is actively pursuing overseas acquisitions and enhancing its global industrial layout, particularly in Thailand[153]. - The company is focusing on advanced technologies such as 3D printing and cold spraying to enhance its production capabilities[154]. - The company is accelerating the investment in the liquid rocket engine thrust chamber materials project to meet rapidly growing market demands[154]. Governance and Compliance - The company has received a standard unqualified audit report from its accounting firm, ensuring the accuracy and completeness of the financial report[6]. - The company has confirmed that all board members attended the board meeting, ensuring governance compliance[6]. - The company has not reported any special arrangements in corporate governance[6]. - The company has not faced any significant adverse impacts from competition with its controlling shareholder[158]. - All proposals presented at the shareholder meetings were approved without any rejections[158]. Risks and Challenges - The company has identified potential risks in its business development, which investors should be aware of[7]. - The company is exposed to risks from raw material price fluctuations, particularly copper, which could adversely affect operational performance if not managed effectively[110]. - The company faces risks related to the inability to digest new production capacity from projects that have been completed, which may affect market expansion and sales capabilities[109]. - The company must monitor the emergence of new technologies and materials, such as cobalt-based high-temperature alloys, which could impact demand for its high-performance chromium products[114]. Employee and Management Changes - The company has a R&D team of 98 members, constituting 8.15% of total employees, highlighting the importance of maintaining technical talent and partnerships with research institutions[107][108]. - The total remuneration for all directors, supervisors, and senior management personnel at the end of the reporting period amounted to 6.5055 million RMB[177]. - Wang Wenbin resigned as General Manager due to the company's development strategy needs[178]. - Zhang Hang was appointed as General Manager to align with the company's development strategy[178]. Operational Efficiency - The company has initiated a sustainability strategy aimed at achieving carbon neutrality by 2030, with an investment of RMB 50 million allocated for this purpose[16]. - The company is focusing on enhancing its digital transformation to improve operational efficiency and product quality[27]. - Operational efficiency improvements have reduced costs by 5%, contributing to higher profit margins[169].